CMS negotiated prices · Medicare Part D
Medicare's negotiated drug prices for 2026 and 2027
The 30-day prices CMS published for the 25 drugs negotiated so far, each against its list price. The hatched part of a bar is the gap between the two.
No negotiated price published for that name in this year. Try the other year, or the generic name.
At most, per one-month supply of each Part B- and Part D-covered insulin (other costs may apply). Medicare.gov
Sources. Negotiated prices and list prices: CMS fact sheets for 2026 and 2027, retrieved 2026-10-04. List prices are CMS's 30-day wholesale acquisition cost figures (CY 2023 for the 2026 drugs, CY 2024 for the 2027 drugs). Prices apply from 1 January of each year. These are the prices CMS published, not what any one person pays: out-of-pocket cost depends on the plan's cost-sharing and is not shown here.